Thrombolytic Therapy Procedure: Types, What to Expect, Risks, and Recovery
Updated: 6 days ago
Written and medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026 · How we review
Quick Answer: What is thrombolytic therapy?
Thrombolytic therapy is a treatment that uses clot-dissolving medicines, given through an IV line or a catheter, to restore blood flow. It is used for heart attack, ischemic stroke, pulmonary embolism, deep vein thrombosis, and peripheral artery disease. In emergencies, it works best when started within two hours of symptoms. The main risk is internal bleeding. [1]
What the research says
Earlier treatment for stroke brings a bigger benefit. In a pooled analysis of 6,756 patients from nine randomized trials, treatment within 3 hours led to recovery without significant disability in 32.9% of patients versus 23.1% with control; between 3 and 4.5 hours, the figures were 35.3% versus 30.1%. Symptomatic brain bleeding rose to 6.8% versus 1.3%. (Emberson et al., Lancet, 2014) [2]
For lung clots, survival improves but bleeding rises. A meta-analysis of 16 trials with 2,115 patients found fewer deaths with thrombolysis than with blood thinners alone (2.17% vs. 3.89%), but more major bleeding (9.24% vs. 3.42%) and brain bleeding (1.46% vs. 0.19%). (Chatterjee et al., JAMA, 2014) [3]
In heart attack, every hour counts. Across nine trials of 58,600 patients, people with ST elevation or bundle-branch block had about 30 fewer deaths per 1,000 when treated within 6 hours and about 20 fewer per 1,000 at 7 to 12 hours, with about 4 extra strokes per 1,000. (Fibrinolytic Therapy Trialists' Collaborative Group, Lancet, 1994) [4]
Key takeaways
Thrombolytic therapy (thrombolysis) dissolves blood clots to protect organs and tissues from damage.
It is given either through an IV line into the bloodstream or through a catheter placed directly at the clot.
Speed matters: the target is within 2 hours of symptoms and 30 minutes of hospital arrival.
About 5% of people have a major bleed and about 1% have a brain bleed, with a higher brain-bleed risk when treating stroke.
Most people spend 1 to 3 days in hospital, and many need blood thinners afterward.
Already reading about how clot-busting drugs work? Our guide to how fibrinolytic drugs dissolve blood clots explains the medicine itself. This article walks you through the procedure.
What conditions does thrombolytic therapy treat?
Thrombolytic therapy treats conditions where a blood clot suddenly blocks a major artery or vein, or where blood thinners have not cleared a clot. [1]
Doctors may use it for:
Heart attack (myocardial infarction), including blocked coronary arteries when stents or surgery are not an option. See our guide to STEMI heart attacks.
Ischemic stroke, caused by a clot blocking blood flow to the brain. Learn more about thrombotic stroke and embolic stroke.
Pulmonary embolism, a blood clot in the lungs. Read our pulmonary embolism guide.
Deep vein thrombosis (DVT) that blocks venous blood flow, causing pain and blue skin coloring (cyanosis), or that does not improve with blood thinners. See our DVT complete guide.
Peripheral artery disease (PAD) and a sudden drop in blood flow to the arms or legs (acute peripheral arterial occlusion). Read about PAD.
Clots inside blood vessels (thrombosis) in general.
Blocked long-term catheters (catheter occlusion).
Condition | Typical setting |
Heart attack | Emergency |
Ischemic stroke | Emergency |
Pulmonary embolism | Emergency, or when blood thinners have not worked |
Deep vein thrombosis | Often scheduled, or when blood thinners have not worked |
Peripheral artery disease | Often scheduled |
Catheter occlusion | Planned treatment of a blocked line |
What are the types of thrombolytic therapy?
Thrombolytic therapy comes in three types: systemic thrombolysis, catheter-directed thrombolysis, and mechanical thrombectomy. [1]
Type | How it is given | Often used for | Typical time |
Systemic thrombolysis | IV line in an arm vein; medicine travels through the bloodstream | Emergencies: heart attack, pulmonary embolism, stroke | About 1 hour |
Catheter-directed thrombolysis | A long, thin tube delivers medicine straight to the clot | Scheduled treatment of DVT and PAD | Up to 48 hours |
Mechanical thrombectomy | A catheter with a rotating or ultrasound device, suction cup, or fluid jet breaks up or suctions the clot | Sometimes combined with catheter-directed thrombolysis | Part of the catheter procedure |
When a clot needs to be physically removed, doctors may also consider an embolectomy.
Who should not have thrombolytic therapy?
Thrombolytic therapy is not recommended for people with conditions that raise the risk of bleeding. [1]
These include:
Active bleeding
A recent brain bleed (intracranial hemorrhage). Read more about hemorrhagic stroke.
Recent brain or spine surgery
Severe high blood pressure (hypertension)
Severe kidney disease
A recent traumatic brain injury
Pregnant women and older adults also have a higher risk of complications, so the care team weighs benefits and risks carefully. [1]
How fast does thrombolytic therapy need to start?
Thrombolytic therapy for an emergency such as a heart attack, stroke, or pulmonary embolism should start as soon as possible. For the best outcomes, the care team aims to begin within two hours of when symptoms started and within 30 minutes of arrival at the hospital. [1]
If you notice signs of a stroke or heart attack, call emergency services right away. Do not drive yourself to the hospital.
What happens during systemic thrombolysis?
Systemic thrombolysis delivers clot-dissolving medicine through an IV line, usually in an intensive care unit (ICU), and the procedure takes about one hour. [1]
The team usually:
Gives you a sedative to help you relax.
Numbs the IV site with a local anesthetic.
Places the IV line in a vein in your arm. The medicine travels through your bloodstream until it reaches the clot.
Removes the IV after the procedure and closes the site with a sterile plug.
What happens during catheter-directed thrombolysis?
Catheter-directed thrombolysis delivers medicine through a thin tube placed directly at the clot, and it is usually a scheduled procedure. [1]
The team usually:
Gives you a sedative to help you relax.
Numbs the area where the catheter goes in.
Makes a small cut in the neck, groin, arm, or behind the knee, then guides the catheter through a vein.
Sends the medicine through the catheter to the clot. A device at the catheter tip may also break up or suction the clot (mechanical thrombectomy).
Looks for narrowed areas in the vein that may have caused the clot and may open them with angioplasty or a stent.
Removes the catheter and closes the site with a sterile plug.
The medicine can take up to two days to work, so you stay in hospital. During this time, the team uses X-rays to track the clot and monitors your heart, lungs, and blood pressure. It can take up to 48 hours for the clot to dissolve. [1]
How do doctors check that the clot is gone?
Doctors confirm whether the clot is fully removed with imaging tests after thrombolytic therapy. [1]
Test | What it shows |
Angiogram | Blood flow through the arteries |
CT scan | Detailed images of the treated area |
Echocardiogram | Heart structure and function |
Venogram (X-ray of the veins) | How blood moves through the veins |
What are the benefits of thrombolytic therapy?
Thrombolytic therapy dissolves blood clots that, if left untreated, may cause disability, loss of limbs, or death. [1] By restoring blood flow quickly, it limits damage to the organs and tissues that the clot was starving of oxygen.
What are the risks of thrombolytic therapy?
The main risk of thrombolytic therapy is internal bleeding: about 5% of people have a major bleed, and about 1% have a brain bleed, though brain bleeding is more common (about 6 in 100) when it is used for stroke. [1]
Other possible risks include:
Risk | What it means |
Allergic reaction | The body reacts to the medicine |
Bleeding in the nose, stool, or urine | Visible bleeding from other sites |
Bleeding or bruising at the IV or catheter site | Local bleeding where the line was placed |
Blood vessel damage | Injury to the vessel used for treatment |
Kidney damage | Higher risk in people with diabetes |
Low blood pressure (hypotension) | Blood pressure drops during or after treatment |
Clot movement | Part of the clot travels to another part of the body |
Swollen tissue (angioedema) | Swelling under the skin |
Ventricular arrhythmia | Abnormal heart rhythm from the lower heart chambers |
People with an inherited or acquired tendency to clot may need extra planning. Read our guide to blood clotting disorders.
What is recovery like after thrombolytic therapy?
Recovery after thrombolytic therapy usually means at least one day in the ICU and one to three days in hospital while the team makes sure the clot has dissolved. [1]
Feature | Systemic thrombolysis | Catheter-directed thrombolysis |
After the procedure | Monitoring in hospital | More medicine may be given to finish dissolving the clot (12 to 14 hours) |
Compression stocking | Not part of routine care | Placed on the arm or leg if treatment was for a blocked limb vessel; not needed after pulmonary embolism or heart attack |
Blood thinners | Likely needed at home to prevent new clots | Usually needed for 3 to 6 months |
Learn how one common long-term blood thinner works in our guide to warfarin. Some people who cannot take blood thinners may need other options, such as a vena cava filter.
How successful is thrombolytic therapy?
Thrombolytic therapy usually dissolves blood clots successfully, but up to 25% of people still have a clot afterward, and about 12% develop a clot or blood vessel blockage again. [1] Your doctor may suggest another minimally invasive procedure to treat the underlying cause of the clot.
When should you call a doctor after thrombolytic therapy?
Call your healthcare provider after thrombolytic therapy if you notice any of these symptoms: [1]
Chest pain
Continued bleeding or leaking fluid at the IV or catheter site
Fever
Nausea or a headache that keeps getting worse
Tingling or numbness in your arms or legs
Warmth or redness at the IV or catheter site
Worsening pain or swelling at the IV or catheter site
For a deeper clinical overview written for health professionals, see this open-access review of thrombolytic therapy.
Conclusion
Thrombolytic therapy is a time-critical treatment that dissolves dangerous blood clots in the heart, brain, lungs, arms, and legs. It can be given quickly through an IV in an emergency, or directly into the clot through a catheter over one to two days. The benefits can include avoiding disability, limb loss, and death, while the main risk is bleeding. Most people stay in hospital for a few days and many continue blood thinners afterward, with follow-up to treat the cause of the clot.
Know the signs, act fast. If you or someone near you shows signs of a stroke or heart attack, call emergency services immediately. To keep learning, explore our guides to deep vein thrombosis, pulmonary embolism, and stroke, and follow us on Instagram and YouTube for clear, evidence-based health updates.
FAQ
What is thrombolytic therapy used for?
Thrombolytic therapy is used to dissolve blood clots in heart attack, ischemic stroke, pulmonary embolism, deep vein thrombosis, and peripheral artery disease. It is also used to clear blocked long-term catheters.
How long does thrombolytic therapy take?
Thrombolytic therapy through an IV line usually takes about one hour. Catheter-directed treatment can take up to 48 hours for the clot to dissolve, so patients stay in hospital during that time.
Is thrombolytic therapy the same as thrombolysis?
Thrombolytic therapy and thrombolysis are two names for the same treatment. Both refer to using medicines to dissolve blood clots and restore blood flow.
What is the biggest risk of thrombolytic therapy?
Internal bleeding is the biggest risk of thrombolytic therapy. About 5% of people have a major bleed, and about 1% have a brain bleed, with a higher brain-bleed risk when it is used for stroke.
Who cannot have thrombolytic therapy?
People with active bleeding, a recent brain bleed, recent brain or spine surgery, severe high blood pressure, severe kidney disease, or a recent traumatic brain injury usually cannot have thrombolytic therapy. Pregnant women and older adults also face a higher risk of complications.
How long is the hospital stay after thrombolytic therapy?
Most people spend at least one day in the ICU and one to three days in hospital after thrombolytic therapy. The care team uses this time to confirm the clot has dissolved.
Will I need blood thinners after thrombolytic therapy?
Blood thinners are often needed after thrombolytic therapy to prevent new clots. After catheter-directed treatment, they are usually taken for three to six months.
When should thrombolytic therapy start for a stroke or heart attack?
Thrombolytic therapy should start as soon as possible in an emergency. The target is within two hours of symptom onset and within 30 minutes of arriving at the hospital.
What is catheter-directed thrombolysis?
It is a procedure that places a thin tube right at the clot to deliver clot-dissolving medicine. It is usually scheduled, and you may stay in the hospital while the clot breaks down.
How do doctors know the clot is gone?
Doctors use imaging tests after treatment to see whether the clot has dissolved and blood is flowing again. The results help them decide on next steps.
Related Reading
Thrombolytics: How Clot-Busting Drugs Work, Types, Timing and Risks explains how clot-busting drugs work and which ones doctors use.
Stroke: Symptoms, Causes, Diagnosis, and Treatment — A Complete Guide covers stroke warning signs and emergency treatment options.
Pulmonary Embolism Guide: Symptoms, Causes, Diagnosis, and Treatment explains how a blood clot in the lungs is found and treated.
Thrombectomy: How Doctors Remove a Blood Clot, Risks, and Recovery describes how doctors remove a clot with a device and what recovery involves.
References
Cleveland Clinic. Thrombolytic Therapy: Uses and Side Effects. Cleveland Clinic. Last updated June 16, 2022. https://my.clevelandclinic.org/health/treatments/23345-thrombolytic-therapy
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935. PMID 25106063. https://doi.org/10.1016/S0140-6736(14)60584-5
Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311(23):2414-2421. PMID 24938564. https://doi.org/10.1001/jama.2014.5990
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343(8893):311-322. PMID 7905143. https://pubmed.ncbi.nlm.nih.gov/7905143/
Medical disclaimer
This article is for general education only and does not replace professional medical advice, diagnosis, or treatment. Always ask your doctor or another qualified health provider about a medical condition or treatment. If you think you are having a medical emergency, call your local emergency number right away.
Comments